Typically, CD47 can allow tumor cells to evade macrophage-mediated elimination; consequently, the use of specific anti-CD47 antibodies can restore this event, and this is the rationale for the anti-CD47 antibody used in tumor therapy (282). The gene discussed is CD47; the disease is neoplasm.